Santhera Receives Swissmedic Approval of AGAMREE® - GlobeNewswire

Santhera Receives Swissmedic Approval of AGAMREE®  GlobeNewswire

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy - Indian Pharma Post

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy  Indian Pharma Post

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein...

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)  the-scientist.com

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)  PR Newswire

Medicinal product safety - interpharma.ch

Medicinal product safety  interpharma.ch

Swissmedic, the Swiss Agency for Therapeutic Products, Reports Another Loss in the Millions - blu...

Swissmedic, the Swiss Agency for Therapeutic Products, Reports Another Loss in the Millions  blue News

Swissmedic plans job cuts amid mounting financial pressures - SWI swissinfo.ch

Swissmedic plans job cuts amid mounting financial pressures  SWI swissinfo.ch

Swissmedic approves IFINWIL for children with high-risk neuroblastoma - Pharmaceutical Technology

Swissmedic approves IFINWIL for children with high-risk neuroblastoma  Pharmaceutical Technology

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations ...

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations  RAPS.org

Pharmaceutical Advertising Laws and Regulations Report 2025 - 2026 Switzerland - ICLG

Pharmaceutical Advertising Laws and Regulations Report 2025 - 2026 Switzerland  ICLG

Switzerland Mutual Recognition Agreement - fda.gov

Switzerland Mutual Recognition Agreement  fda.gov

Switzerland monitors Japanese concerns over Tavneos drug - SWI swissinfo.ch

Switzerland monitors Japanese concerns over Tavneos drug  SWI swissinfo.ch

Tinlarebant earns Swiss orphan drug status for Stargardt disease - Ophthalmology Times

Tinlarebant earns Swiss orphan drug status for Stargardt disease  Ophthalmology Times

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the...

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy  Global Biotechnology Company

Swissmedic survey finds drug approval timelines slower than EMA, FDA - RAPS.org

Swissmedic survey finds drug approval timelines slower than EMA, FDA  RAPS.org

Swiss medicines regulator responds to Trump’s paracetamol claim - SWI swissinfo.ch

Swiss medicines regulator responds to Trump’s paracetamol claim  SWI swissinfo.ch

Euro Roundup: Swissmedic reorganizes to clarify medical device and market surveillance responsibi...

Euro Roundup: Swissmedic reorganizes to clarify medical device and market surveillance responsibilities  RAPS.org

Euro Roundup: Switzerland updates legislation to improve clinical trial framework - RAPS.org

Euro Roundup: Switzerland updates legislation to improve clinical trial framework  RAPS.org

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeu...

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics  Greater Geneva Bern area (GGBa)

First Malaria Drug Approved for Newborns and Small Babies - Infectious Disease Advisor

First Malaria Drug Approved for Newborns and Small Babies  Infectious Disease Advisor

Swissmedic approves J&J COVID-19 vaccine booster - Reuters

Swissmedic approves J&J COVID-19 vaccine booster  Reuters

Drug & Medical Device Litigation Laws and Regulations Report 2026 Switzerland - ICLG

Drug & Medical Device Litigation Laws and Regulations Report 2026 Switzerland  ICLG

Navigating the complexity: reflections on the development of perioperative cancer treatments - Th...

Navigating the complexity: reflections on the development of perioperative cancer treatments  The Lancet

EU Regulatory Roundup: Swissmedic Details Plans to Align Combination Product Rules With EU - RAPS...

EU Regulatory Roundup: Swissmedic Details Plans to Align Combination Product Rules With EU  RAPS.org

Federated learning: a privacy-preserving approach to data-centric regulatory cooperation - Frontiers

Federated learning: a privacy-preserving approach to data-centric regulatory cooperation  Frontiers

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters

The first drug to treat infants sick with malaria is approved by Swiss authority - AP News

The first drug to treat infants sick with malaria is approved by Swiss authority  AP News

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - ...

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News  blue News

Navigating The 2025 Medtech Regulatory Landscape In Switzerland And The U.K. - Med Device Online

Navigating The 2025 Medtech Regulatory Landscape In Switzerland And The U.K.  Med Device Online

Switzerland Guides Innovation in Clinical Trial Regulations - Applied Clinical Trials Online

Switzerland Guides Innovation in Clinical Trial Regulations  Applied Clinical Trials Online

Idorsia introduces Quviviq in Switzerland for chronic insomnia treatment - Pharmaceutical Technology

Idorsia introduces Quviviq in Switzerland for chronic insomnia treatment  Pharmaceutical Technology

Landmark listing of first three countries as WHO-Listed regulatory Authorities - World Health Org...

Landmark listing of first three countries as WHO-Listed regulatory Authorities  World Health Organization (WHO)

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible  Swissmedic

Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Swit...

Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis  Business Wire

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulato...

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies?  PublicEye

Micro-Sphere to pump $22M into its Swiss spray-drying and capsule-filling plant - Fierce Pharma

Micro-Sphere to pump $22M into its Swiss spray-drying and capsule-filling plant  Fierce Pharma

Swiss newspaper challenges drug advertising allegations - SWI swissinfo.ch

Swiss newspaper challenges drug advertising allegations  SWI swissinfo.ch

Swiss Pharma Strength - PharmTech.com

Swiss Pharma Strength  PharmTech.com

CHUV introduces Switzerland's first gut-balancing medication - Greater Geneva Bern area (GGBa)

CHUV introduces Switzerland's first gut-balancing medication  Greater Geneva Bern area (GGBa)

No, Switzerland hasn’t banned AstraZeneca vaccine, but requested more data for approval - Africa ...

No, Switzerland hasn’t banned AstraZeneca vaccine, but requested more data for approval  Africa Check

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs  SWI swissinfo.ch

Improving international collaboration – MHRA and Swissmedic sign MoU - GOV.UK

Improving international collaboration – MHRA and Swissmedic sign MoU  GOV.UK

Swiss regulator approves updated Covid-19 vaccine - SWI swissinfo.ch

Swiss regulator approves updated Covid-19 vaccine  SWI swissinfo.ch

United Kingdom – Switzerland Regulatory Cooperation - GOV.UK

United Kingdom – Switzerland Regulatory Cooperation  GOV.UK

Astrasana Group receives Swissmedic license for the cultivation of medical cannabis - Presseporta...

Astrasana Group receives Swissmedic license for the cultivation of medical cannabis  Presseportal.ch

Seizures of illegally imported medicines triple in Switzerland - SWI swissinfo.ch

Seizures of illegally imported medicines triple in Switzerland  SWI swissinfo.ch

CUTISS receives Swissmedic approval for Phase II trials - Startupticker.ch

CUTISS receives Swissmedic approval for Phase II trials  Startupticker.ch

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections - SWI swissinfo.ch

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections  SWI swissinfo.ch

India-made stimulants, COVID-related drugs dominate illegal imports in Switzerland - ET HealthWorld

India-made stimulants, COVID-related drugs dominate illegal imports in Switzerland  ET HealthWorld

Swiss doctors warn against sleep gummy bear trend - lenews.ch

Swiss doctors warn against sleep gummy bear trend  lenews.ch

Swiss medicine regulator warns against purchase of fake Ozempic - SWI swissinfo.ch

Swiss medicine regulator warns against purchase of fake Ozempic  SWI swissinfo.ch

Emergency vaccine approval not legal option in Switzerland - SWI swissinfo.ch

Emergency vaccine approval not legal option in Switzerland  SWI swissinfo.ch

Covid vaccinations will be free in Switzerland - lenews.ch

Covid vaccinations will be free in Switzerland  lenews.ch

First Covid-19 vaccine approved for Swiss use - SWI swissinfo.ch

First Covid-19 vaccine approved for Swiss use  SWI swissinfo.ch

Swiss seize 1 million fake Xanax tablets headed for Egypt - Politics - Egypt - Ahram Online

Swiss seize 1 million fake Xanax tablets headed for Egypt - Politics - Egypt  Ahram Online

Cough medicine containing psychoactive substances not to be sold in drugstores - Bundesverwaltung...

Cough medicine containing psychoactive substances not to be sold in drugstores  Bundesverwaltungsgericht (BVGer)

Swiss regulators get tough on illegal fresh cell therapy - SWI swissinfo.ch

Swiss regulators get tough on illegal fresh cell therapy  SWI swissinfo.ch